Mike Wilson: 2022 Equity Outlook Feedback and Debates
Listen now
Description
With the release of our outlook for the coming year comes a cycle of feedback and debates from clients and investors. We look at those discussions around equity markets, valuations, and more in 2022.
More Episodes
With interest in anti-obesity medications growing significantly, the head of our European Pharmaceuticals Team examines just how large that market could become.
Published 04/25/24
Published 04/25/24
As the US presidential election remains closely contested, our experts discuss what a change in administration could mean for European equities in terms of trade, China relations and other key issues.
Published 04/24/24